Pfizer mulls possible OTC switch for Lipitor

Share this article:

Pfizer is reportedly weighing an attempt at an over-the-counter switch for Lipitor – a move that could help the company recoup some of its losses when the $11 billion drug loses nationwide exclusivity in November. But the reception from analysts has been muted so far. Pfizer is exploring the possibility of a branded generic, as well as an OTC switch, according to several sources.


Share this article:

More in Products

Higher rates of mortality seen with benzodiazepine sedatives, study says

Continuous infusion benzodiazepines, a group of sedatives often used to treat intensive-care unit patients on ventilators, are linked to an increased likelihood of death compared to those who received propofol, a new study says.

Drive Medical introduces long-term care beds

Drive Medical introduces long-term care beds

Drive Medical is offering four new long-term care beds, including two models designed with the bariatric resident in mind.

New footwear sanitizing system released

New footwear sanitizing system released

Best Sanitizers Inc. has announced the HACCP SmartStep™ Footwear Sanitizing System. The system reduces cross-contamination from footwear for employees working in labs, clean rooms or in pharmaceutical plants.